Zobrazeno 1 - 10
of 131
pro vyhledávání: '"H, Sevelius"'
Autor:
Pérez-Nogués, Marcos1 (AUTHOR) mperez.vet@hotmail.com, Manso-Díaz, Gabriel2 (AUTHOR) gmanso@ucm.es, Spirito, Michael3 (AUTHOR) mspirito@hagyard.com, López-Sanromán, Javier2 (AUTHOR)
Publikováno v:
Animals (2076-2615). Apr2024, Vol. 14 Issue 7, p1122. 10p.
Publikováno v:
Pharmacotherapy. 10(6 ( Pt 2))
In humans, ketorolac is completely bioavailable and its kinetics are linear. It is absorbed rapidly (half-life for absorption 3.8 min) after oral (fasting) and intramuscular administration; food delays but does not reduce its absorption. The drug is
Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease
Publikováno v:
Gastroenterology. 89:555-561
This study was designed to compare the effects of enprostil, a synthetic dehydro-prostaglandin E2, on 24-h intragastric pH and serum gastrin profile in patients with duodenal ulcer disease. The dosing regimen included 3 enprostil groups: 35 microgram
1 In the first of a series of trials with naproxen sodium it was shown that patients achieved significantly earlier and higher plasma levels of naproxen when naproxen sodium was administered. 2 In a second study comparing naproxen with naproxen sodiu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d5d829011f4c3084c5dafb2239fd7a
https://europepmc.org/articles/PMC1430062/
https://europepmc.org/articles/PMC1430062/
Publikováno v:
The New England journal of medicine. 291(11)
Publikováno v:
Pharmaceutical research. 6(1)
Ketorolac tromethamine (KT), a potent analgesic with cyclooxygenase inhibitory activity, was administered in an open, randomized, single-dose study of Latin-square design to 12 healthy male volunteers. Doses of 30 mg oral (po) and 30, 60, and 90 mg i
Publikováno v:
Gastroenterology. 88(1 Pt 2)
Prostaglandins protect against aspirin-induced damage to the gastrointestinal tract. This study tested the ability of enprostil, a synthetic analog of prostaglandin E2, given concurrently to prevent gastroduodenal injury. Twenty-four healthy subjects
Autor:
W H, Rooks, P J, Maloney, L D, Shott, M E, Schuler, H, Sevelius, A M, Strosberg, L, Tanenbaum, A J, Tomolonis, M B, Wallach, D, Waterbury
Publikováno v:
Drugs under experimental and clinical research. 11(8)
Ketorolac tromethamine[(+/-)-5(benzoyl)-2,3-dihydro-1N-pyrrolizine-1-carboxylic acid tris hydroxymethylaminomethane salt] is a highly potent member of a new class of compounds having analgesic and anti-inflammatory activity. When given orally in test
Publikováno v:
The Journal of the Oklahoma State Medical Association. 56
Publikováno v:
Archives of pathology. 73